By www.reliableresearchtimes.com
Global And Japan Progressive Supranuclear Palsy Market Size, Status And Forecast 2024-2031 Story
108
$ 3900
Progressive Supranuclear Palsy Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Merck & Co., Inc. Aton Pharma, Inc. Bristol Myers Squibb (BMS) GlaxoSmithKline plc Novartis AG Teva Pharmaceutical Industries Ltd. AB Science AbbVie Inc. AlzProtect SAS Cortice Biosciences, Inc. Acorda Therapeutics Inc. Biogen Inc.